Taipei, Thursday, April 17, 2014 12:59 (GMT+8)
partly cloudy
Taipei
30°C
Taiwan PCB makers ramping up capacity - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Monday 19 November 2012]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$67.8 on the TSE on Wednesday, April 16, 2014.
    The company has reported consolidated revenues of NT$138 million for March 2014, representing a 9.7% increase on month and 25.6% drop on year.
    For the fourth quarter of 2013, the company totaled NT$354 million in consolidated revenues, down 22% sequentially and down 26.5% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    17-Apr 106   67.80 68.20 67.60 67.80+0.00+0.00%  
    16-Apr 122 109 8,220,965 67.30 67.80 67.20 67.80+0.50+0.74% 67.80 67.50
    15-Apr 59 66 3,988,549 67.10 67.50 67.10 67.30+0.30+0.45% 67.30 67.20
    14-Apr 180 144 12,065,872 67.30 67.40 66.80 67.00-0.30-0.45% 67.10 67.00
    11-Apr 202 175 13,610,786 67.50 67.80 67.30 67.30-0.60-0.88% 67.60 67.30
    10-Apr 183 152 12,416,676 68.00 68.20 67.60 67.90-0.30-0.44% 68.00 67.80
    9-Apr 143 108 9,716,376 67.80 68.20 67.70 68.20+0.30+0.44% 68.30 68.20
    8-Apr 167 98 11,338,091 68.00 68.50 67.70 67.90-0.10-0.15% 68.10 67.90
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Mar 2013 - Mar 2014 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Mar-14

    138

    9.7%

    (25.6%)

    423

    (19.2%)

    Feb-14

    126

    (20.7%)

    (20.4%)

    285

    (15.7%)

    Jan-14

    159

    26.5%

    (11.6%)

    159

    (11.6%)

    Dec-13

    126

    9.8%

    (20.5%)

    1,829

    (9.7%)

    Nov-13

    114

    (0%)

    (27.8%)

    1,704

    (8.8%)

    Oct-13

    114

    (25.9%)

    (30.9%)

    1,589

    (7%)

    Sep-13

    154

    0.3%

    8.4%

    1,475

    (4.5%)

    Aug-13

    154

    5.6%

    0.2%

    1,320

    (5.8%)

    Jul-13

    146

    3%

    (8.8%)

    1,166

    (6.5%)

    Jun-13

    142

    (17.9%)

    (14.3%)

    1,021

    (6.2%)

    May-13

    173

    (5.3%)

    (6.4%)

    879

    (4.8%)

    Apr-13

    182

    (2%)

    (9.5%)

    706

    (4.4%)

    Mar-13

    186

    17.4%

    (8.8%)

    524

    (2.4%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Apex: Consolidated revenues, 4Q12 - 4Q13 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    4Q-13

    354

    (22%)

    (26.5%)

    1,829

    (9.7%)

    3Q-13

    454

    (8.5%)

    (0.4%)

    1,475

    (4.5%)

    2Q-13

    497

    (5.2%)

    (9.9%)

    1,021

    (6.2%)

    1Q-13

    524

    8.7%

    (2.4%)

    524

    (2.4%)

    4Q-12

    482

    5.7%

    (3.1%)

    2,026

    8%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 4Q12 - 4Q13 (NT$k)

    Item

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    4Q-2012

    Current assets

    1,447,851

    1,347,766

    1,644,885

    1,922,635

    1,815,585

    Intangible assets

    26,174

    17,236

    17,816

    14,190

    14,554

    Non-current assets

    1,276,137

    1,341,620

    1,027,811

    967,210

    929,767

    Assets

    2,723,988

    2,689,386

    2,672,696

    2,889,845

    2,745,352

    Current liabilities

    383,354

    382,837

    416,522

    353,703

    336,313

    Non-current liabilities

    420,118

    421,334

    421,188

    419,978

    419,273

    Liabilities

    803,472

    804,171

    837,710

    773,681

    755,586

    Stockholders' equity

    1,920,516

    1,885,215

    1,834,986

    2,116,164

    1,989,766

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Apex: Consolidated income statement, 4Q12 - 4Q13 (NT$k)

    Item

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    4Q-2012

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

     

     

     

     

     

     

    486,607

     

    Operating revenue

    354,410

    72.8%

    454,277

    93.4%

    496,560

    102%

    523,974

    107.7%

    481,967

    99%

    Gross profit (loss) from operations

    106,527

    21.9%

    120,929

    24.9%

    169,175

    34.8%

    171,812

    35.3%

    190,327

    39.1%

    Operating expenses

    59,426

    12.2%

    51,361

    10.6%

    56,054

    11.5%

    52,611

    10.8%

    52,896

    10.9%

    Operating income (loss)

    48,747

    10%

    67,922

    14%

    113,121

    23.2%

    119,201

    24.5%

    137,431

    28.2%

    Non-operating revenues and gains

     

     

     

     

     

     

    25,800

    5.3%

    1,866

    0.4%

    Non-operating expenses and losses

    -3,812

    -0.8%

    -8,211

    -1.7%

    0

    0%

     

     

    -6,023

    -1.2%

    Income from continuing operations before income tax

    44,935

    9.2%

    59,711

    12.3%

    176,732

    36.3%

    145,001

    29.8%

    131,412

    27%

    Net income (loss)

    30,322

    6.2%

    51,591

    10.6%

    163,005

    33.5%

    125,925

    25.9%

    125,637

    25.8%

    Diluted earnings per share (NT$)

    0.1

     

    0.5

     

    1.6

     

    1.2

     

    1.2

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

  • Apex Biotechnology full profile
Realtime news
  • China white-box tablet vendors gaining foothold

    IT + CE | 28min ago

  • Southern Taiwan Science Park sees January-February revenues down 5.42% on year

    Displays | 42min ago

  • Young Optics to deal out 2013 cash dividend of NT$1.88

    IT + CE - Stockwatch | 46min ago

  • Unitech to ramp up capacity for any-layer HDI and flex-rigid boards

    Bits + chips | Apr 16, 21:46

  • FIC ruggedized tablet subsidiary receives procurement orders from Brazil

    IT + CE | Apr 16, 21:24

  • China market: Local smartphone vendors accelerating LTE launches

    Mobile + telecom | Apr 16, 21:13

  • Taiwan market: Epson launches CISS printers

    IT + CE | Apr 16, 21:10

  • O-Film expected to produce for 35% of handset touch panels in 2014

    Displays | Apr 16, 20:20

  • Taiwan solar cell makers see surging orders from China

    Green energy | Apr 16, 20:17

  • Digitimes Research: In-house no longer useful for Qualcomm

    Before Going to Press | Apr 16, 20:58

Pause
 | 
View more

17-Apr-2014 11:48 (GMT+8)

 LastChange

TAIEX (TSE)8940.99+17.17+0.19% 

TSE electronic340.94+0.92+0.27% 

GTSM (OTC)145.29+1.28+0.89% 

OTC electronic180.3+1.09+0.61% 

Global tablet tracker
China smartphone tracker
2014 global smartphone market forecast
  • 2014 China smartphone market and industry - Forecast and analysis

    Digitimes Research expects demand in the domestic China market to reach 422 million smartphones in 2014, with 278 million units contributed by China-based smartphone vendors.

  • 2014 global mobile application processor market forecast

    This report provides a market forecast of the 2014 application processor market. The analysis includes the development and market strategies for each major AP vendor, thus providing readers with a roadmap for how the market will develop in 2014 and the role of the major players.

  • 2014 global tablet demand forecast

    This report analyzes the main players, their strategies and shipments forecasts for 2014, as well as other factors contributing to either growth or decline in various segments within the tablet market, with a particular focus on Apple, Google, Samsung, and Microsoft, along with whitebox vendors.